Literature DB >> 32634451

Circulating products of C-type natriuretic peptide and links with organ function in health and disease.

Timothy Cr Prickett1, Eric A Espiner2.   

Abstract

Paracrine actions of CNP and rapid degradation at source severely limit study of CNP's many roles in vivo. However provided sensitive and validated assays are used, there is increasing evidence that low concentrations of bioactive CNP in plasma, and the readily detectable concentrations of the bio-inactive processed product of proCNP (aminoterminal proCNP), can be used to advance understanding of the hormone's role in pathophysiology. Provided renal function is normal, concordant changes in both CNP and NTproCNP reflect change in tissue production of proCNP whereas change in CNP alone results from altered rates of bioactive CNP degradation and are reflected in the ratio of NTproCNP to CNP. As already shown in juveniles, where plasma concentration of CNP products are higher and are associated with concurrent endochondral bone growth, measurements of plasma CNP products in mature adults have potential to clarify organ response to stress and injury. Excepting the role of CNP in fetal-maternal welfare, this review examines evidence linking plasma CNP products with function of a wide range of tissues in adults, including the impact of extraneous factors such as nutrients, hormone therapy and exercise.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BNP; Bone turnover markers; Myocardial fibrosis; NTproCNP; Osteocrin; Vascular risk factors

Mesh:

Substances:

Year:  2020        PMID: 32634451     DOI: 10.1016/j.peptides.2020.170363

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

1.  A long-acting C-natriuretic peptide for achondroplasia.

Authors:  Eric L Schneider; Christopher W Carreras; Ralph Reid; Gary W Ashley; Daniel V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-18       Impact factor: 12.779

Review 2.  Physiological and Pathophysiological Effects of C-Type Natriuretic Peptide on the Heart.

Authors:  Akihiro Yasoda
Journal:  Biology (Basel)       Date:  2022-06-14

Review 3.  Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide.

Authors:  Estera Rintz; Grzegorz Węgrzyn; Toshihito Fujii; Shunji Tomatsu
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

Review 4.  Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment.

Authors:  Koichi Yamamoto; Hiromi Rakugi
Journal:  Hypertens Res       Date:  2021-07-21       Impact factor: 3.872

5.  Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19.

Authors:  Sokratis A Apostolidis; Amrita Sarkar; Heather M Giannini; Rishi R Goel; Divij Mathew; Aae Suzuki; Amy E Baxter; Allison R Greenplate; Cécile Alanio; Mohamed Abdel-Hakeem; Derek A Oldridge; Josephine Giles; Jennifer E Wu; Zeyu Chen; Yinghui Jane Huang; Ajinkya Pattekar; Sasikanth Manne; Oliva Kuthuru; Jeanette Dougherty; Brittany Weiderhold; Ariel R Weisman; Caroline A G Ittner; Sigrid Gouma; Debora Dunbar; Ian Frank; Alexander C Huang; Laura A Vella; John P Reilly; Scott E Hensley; Lubica Rauova; Liang Zhao; Nuala J Meyer; Mortimer Poncz; Charles S Abrams; E John Wherry
Journal:  bioRxiv       Date:  2021-05-03

Review 6.  Current Understanding of Pressure Natriuresis.

Authors:  Eun Ji Baek; Sejoong Kim
Journal:  Electrolyte Blood Press       Date:  2021-12-23

7.  Evidence of feedback regulation of C-type natriuretic peptide during Vosoritide therapy in Achondroplasia.

Authors:  Timothy C R Prickett; Eric A Espiner; Melita Irving; Carlos Bacino; John A Phillips; Ravi Savarirayan; Jonathan R S Day; Elena Fisheleva; Kevin Larimore; Ming Liang Chan; George S Jeha
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

8.  Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.

Authors:  Sokratis A Apostolidis; Amrita Sarkar; Heather M Giannini; Rishi R Goel; Divij Mathew; Aae Suzuki; Amy E Baxter; Allison R Greenplate; Cécile Alanio; Mohamed Abdel-Hakeem; Derek A Oldridge; Josephine R Giles; Jennifer E Wu; Zeyu Chen; Yinghui Jane Huang; Jonathan Belman; Ajinkya Pattekar; Sasikanth Manne; Oliva Kuthuru; Jeanette Dougherty; Brittany Weiderhold; Ariel R Weisman; Caroline A G Ittner; Sigrid Gouma; Debora Dunbar; Ian Frank; Alexander C Huang; Laura A Vella; John P Reilly; Scott E Hensley; Lubica Rauova; Liang Zhao; Nuala J Meyer; Mortimer Poncz; Charles S Abrams; E John Wherry
Journal:  Front Immunol       Date:  2022-03-03       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.